Overview
Semen examination part four covers optional procedures, biochemical assays of accessory sex organ function, and advanced analytical techniques used to refine the evaluation of male fertility. Optional indices, such as multiple anomalies index, teratozoospermia index, and sperm deformity index, help assess the extent of structural sperm defects. Biochemical markers, including fructose, zinc, citric acid, acid phosphatase, and alpha-galactosidase, provide information about seminal vesicle and prostate function. This part also introduces computer-aided sperm analysis, which offers automated and quantitative assessment of sperm parameters and supports detailed interpretation of semen quality.
Symptoms
Abnormal findings detected in this phase of semen analysis do not produce direct symptoms but are associated with infertility or reduced reproductive potential. Men may have normal routine semen parameters yet experience difficulty in conception due to impaired accessory gland function or subtle sperm defects. Reduced sperm motility, poor semen quality, or repeated failure of assisted reproductive techniques may prompt the use of these advanced and optional tests.
Causes
Abnormal biochemical markers are caused by the dysfunction of accessory sex organs. Reduced fructose levels indicate impaired seminal vesicle secretion, which may result from absence or inflammation of seminal vesicles, obstruction of the ejaculatory ducts, or testosterone deficiency. Altered zinc, citric acid, and acid phosphatase levels reflect prostatic dysfunction. Structural sperm abnormalities reflected by MAI, TZI, or SDI arise from defective spermatogenesis. Limitations in computer-aided sperm analysis may be caused by improper sample preparation, abnormal sperm concentration, low frame rate, or difficulty distinguishing sperm from debris.
Risk Factors
Risk factors include congenital absence or obstruction of seminal vesicles or ejaculatory ducts, hormonal deficiencies, infections, and chronic inflammation of accessory glands. Men with persistent infertility, abnormal semen biochemistry, or poor response to fertility treatment are more likely to require these advanced assessments. Technical factors such as inadequate sample handling and operator-dependent variability also affect the reliability of optional and automated procedures.
Prevention
Prevention focuses on early identification and management of accessory gland disorders and hormonal imbalances. Treating infections, correcting obstructions, and addressing testosterone deficiency help maintain normal semen biochemistry and sperm function. Standardized sample collection, proper laboratory techniques, and cautious interpretation of computer-aided analysis improve accuracy. Combining optional procedures with routine semen analysis ensures comprehensive evaluation and supports better clinical decision-making in male infertility management.
